Cynosure Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Buy |
7,634
+6,177
| +424% | +$2.5M | 0.35% | 35 |
|
|
2025
Q1 | $725K | Sell |
1,457
-3,329
| -70% | -$1.66M | 0.1% | 100 |
|
|
2024
Q4 | $2.49M | Buy |
4,786
+3,131
| +189% | +$1.63M | 0.37% | 36 |
|
|
2024
Q3 | $1.02M | Buy |
1,655
+209
| +14% | +$129K | 0.15% | 72 |
|
|
2024
Q2 | $800K | Buy |
1,446
+156
| +12% | +$86.3K | 0.13% | 96 |
|
|
2024
Q1 | $750K | Sell |
1,290
-551
| -30% | -$320K | 0.13% | 81 |
|
|
2023
Q4 | $977K | Buy |
1,841
+231
| +14% | +$123K | 0.18% | 97 |
|
|
2023
Q3 | $815K | Buy |
1,610
+87
| +6% | +$44K | 0.25% | 81 |
|
|
2023
Q2 | $795K | Buy |
+1,523
| New | +$795K | 0.24% | 86 |
|
|
2022
Q3 | – | Sell |
-641
| Closed | -$348K | – | 44 |
|
|
2022
Q2 | $348K | Buy |
+641
| New | +$348K | 0.34% | 30 |
|
|
2020
Q2 | – | Sell |
-1,467
| Closed | -$416K | – | 58 |
|
|
2020
Q1 | $416K | Sell |
1,467
-259
| -15% | -$73.4K | 0.3% | 37 |
|
|
2019
Q4 | $561K | Hold |
1,726
| – | – | 0.3% | 31 |
|
|
2019
Q3 | $503K | Sell |
1,726
-610
| -26% | -$178K | 0.27% | 32 |
|
|
2019
Q2 | $686K | Buy |
+2,336
| New | +$686K | 0.32% | 32 |
|